CTSOVSVTGN• 6 Months (Normalized)
CTSO vs VTGN (Cytosorbents Corporation vs Vistagen Therapeutics Inc.)
Showing Closing Date Range from Apr 1 to Sep 28, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
CTSO Performance $4.91
+797.62%
Cytosorbents Corporation
Normalized Baseline0.00%
VTGN Performance $0.37
-38.33%
Vistagen Therapeutics Inc.
Normalized Baseline0.00%
Alpha Spread Margin CTSO LEADS
+835.95 pts
CTSO outperforming by 835.95 percentage points
CTSOVTGN
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
CTSO VTGN
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(121 dates)
| Date | CTSO Price | CTSO Gain (%) | VTGN Price | VTGN Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 23, 2026 | $4.91 | +797.62% | $0.37 | -38.33% | +835.95% |
| Sep 22, 2026 | $- | $0.25 | -58.33% | - | |
| Sep 21, 2026 | $5.51 | +907.31% | $0.23 | -61.67% | +968.98% |
| Sep 18, 2026 | $5.75 | +951.19% | $0.24 | -60.00% | +1011.19% |
| Sep 17, 2026 | $5.76 | +953.02% | $0.23 | -61.67% | +1014.69% |
| Sep 16, 2026 | $5.73 | +947.53% | $0.23 | -61.67% | +1009.20% |
| Sep 15, 2026 | $6.06 | +1007.86% | $0.24 | -60.00% | +1067.86% |
| Sep 14, 2026 | $6.07 | +1009.69% | $0.24 | -59.47% | +1069.16% |
| Sep 11, 2026 | $6.41 | +1071.85% | $0.24 | -60.00% | +1131.85% |
| Sep 10, 2026 | $6.37 | +1064.53% | $0.24 | -60.00% | +1124.53% |
| Sep 09, 2026 | $6.33 | +1057.22% | $0.24 | -60.00% | +1117.22% |
| Sep 08, 2026 | $- | $0.24 | -60.00% | - | |
| Sep 04, 2026 | $0.35 | -36.01% | $0.24 | -60.00% | +23.99% |
| Sep 03, 2026 | $0.35 | -36.01% | $0.25 | -58.33% | +22.32% |
| Sep 02, 2026 | $0.38 | -29.80% | $0.25 | -58.33% | +28.53% |
Page 1 of 9